Emerging role for dysregulated decidualization in the genesis of preeclampsia

Placenta

Volumn 60, Issue , 2017, Pages 119-129

  Conrad, Kirk P ^a   Rabaglino, Maria Belen ^b   Post Uiterweer, Emiel D ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b DEPARTAMENTO DE QUÍMICA   (Argentina)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Decidua; Endometrium; Immune cells; Maternal fetal interface; Placenta; Trophoblast

Indexed keywords

INSULIN GROWTH FACTOR BINDING PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CHORION VILLUS; DECIDUA; DECIDUALIZATION; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; HUMAN; NATURAL KILLER CELL; PLACENTA TISSUE; PREECLAMPSIA; PRIORITY JOURNAL; TRANSCRIPTOMICS; TROPHOBLAST; FEMALE; METABOLISM; PATHOPHYSIOLOGY; PLACENTA; PLACENTA DEVELOPMENT; PREGNANCY;

DECIDUA; FEMALE; GENE EXPRESSION; HUMANS; PLACENTA; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY;

EID: 85021854933     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2017.06.005     Document Type: Article

References (119)

1. Ilekis, J.V., Tsilou, E., Fisher, S., Abrahams, V.M., Soares, M.J., Cross, J.C., Zamudio, S., Illsley, N.P., Myatt, L., Colvis, C., Costantine, M.M., Haas, D.M., Sadovsky, Y., Weiner, C., Rytting, E., Bidwell, G., Placental origins of adverse pregnancy outcomes: potential molecular targets: an executive workshop summary of the eunice kennedy shriver national institute of child health and human development. Am. J. Obstet. Gynecol. 215:1 Suppl (2016), S1–S46.
2. Burton, G.J., Woods, A.W., Jauniaux, E., Kingdom, J.C., Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 30:6 (2009), 473–482.
3. Pijnenborg, R., Vercruysse, L., Hanssens, M., Brosens, I., Endovascular trophoblast and preeclampsia: a reassessment. Pregnancy Hypertens. 1:1 (2011), 66–71.
4. Brosens, I.A., Robertson, W.B., Dixon, H.G., The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet. Gynecol. Annu. 1 (1972), 177–191.
5. Lyall, F., Robson, S.C., Bulmer, J.N., Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension 62:6 (2013), 1046–1054.
6. Khong, T.Y., De Wolf, F., Robertson, W.B., Brosens, I., Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br. J. Obstet. Gynaecol. 93:10 (1986), 1049–1059.
7. Meekins, J.W., Pijnenborg, R., Hanssens, M., McFadyen, I.R., van Asshe, A., A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br. J. Obstet. Gynaecol. 101:8 (1994), 669–674.
8. Zhou, Y., Damsky, C.H., Chiu, K., Roberts, J.M., Fisher, S.J., Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J. Clin. Invest. 91:3 (1993), 950–960.
9. Pijnenborg, R., Vercruysse, L., Hanssens, M., The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27:9–10 (2006), 939–958.
10. Burton, G.J., Jauniaux, E., Placental oxidative stress: from miscarriage to preeclampsia. J. Soc. Gynecol. Investig. 11:6 (2004), 342–352.
11. Redman, C.W., Sargent, I.L., Staff, A.C., IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?. Placenta 35:Suppl (2014), S20–S25.
12. Redman, C.W., Sargent, I.L., Latest advances in understanding preeclampsia. Science 308:5728 (2005), 1592–1594.
13. Ness, R.B., Roberts, J.M., Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am. J. Obstet. Gynecol. 175:5 (1996), 1365–1370.
14. Stubbs, T.M., Lazarchick, J., Horger, E.O. 3rd, Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am. J. Obstet. Gynecol. 150:7 (1984), 885–887.
15. Roberts, J.M., Taylor, R.N., Musci, T.J., Rodgers, G.M., Hubel, C.A., McLaughlin, M.K., Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161:5 (1989), 1200–1204.
16. Conrad, K.P., Benyo, D.F., Placental cytokines and the pathogenesis of preeclampsia. Am. J. Reprod. Immunol. 37:3 (1997), 240–249.
17. Bernstein, I.M., Meyer, M.C., Osol, G., Ward, K., Intolerance to volume expansion: a theorized mechanism for the development of preeclampsia. Obstet. Gynecol. 92:2 (1998), 306–308.
18. Gyselaers, W., Mullens, W., Tomsin, K., Mesens, T., Peeters, L., Role of dysfunctional maternal venous hemodynamics in the pathophysiology of pre-eclampsia: a review. Ultrasound Obstet. Gynecol. 38:2 (2011), 123–129.
19. Khong, Y., Brosens, I., Defective deep placentation. Best. Pract. Res. Clin. Obstet. Gynaecol. 25:3 (2011), 301–311.
20. Kelly, R., Holzman, C., Senagore, P., Wang, J., Tian, Y., Rahbar, M.H., Chung, H., Placental vascular pathology findings and pathways to preterm delivery. Am. J. Epidemiol. 170:2 (2009), 148–158.
21. Ward, K., Taylor, R.N., Genetic factors in the etiology of preeclampsia/eclampsis. Taylor, R.N., Roberts, J.M., Cunningham, F.G., Lindheimer, M.D., (eds.) Chesley's Hypertensive Disorders in Pregnancy, 2015, Academic Press, San Diego, 57–80.
22. Damsky, C.H., Fisher, S.J., Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors. Curr. Opin. Cell Biol. 10:5 (1998), 660–666.
23. Fisher, S.J., McMaster, M., Roberts, J.M., The placental in normal pregnancy and preeclampsia. Taylor, R.N., Roberts, J.M., Cunningham, F.G., Lindheimer, M.D., (eds.) Chesley's Hypertensive Disorders in Pregnancy, 2015, Academic Press, San Diego, 81–94.
24. Hunkapiller, N.M., Fisher, S.J., Chapter 12. Placental remodeling of the uterine vasculature. Methods Enzymol. 445 (2008), 281–302.
25. Lim, K.H., Zhou, Y., Janatpour, M., McMaster, M., Bass, K., Chun, S.H., Fisher, S.J., Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am. J. Pathol. 151:6 (1997), 1809–1818.
26. Brosens, I., Pijnenborg, R., Vercruysse, L., Romero, R., The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am. J. Obstet. Gynecol. 204:3 (2011), 193–201.
27. Zhou, Y., Gormley, M.J., Hunkapiller, N.M., Kapidzic, M., Stolyarov, Y., Feng, V., Nishida, M., Drake, P.M., Bianco, K., Wang, F., McMaster, M.T., Fisher, S.J., Reversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia. J. Clin. Invest. 123:7 (2013), 2862–2872.
28. Rabaglino, M.B., Post Uiterweer, E.D., Jeyabalan, A., Hogge, W.A., Conrad, K.P., Bioinformatics approach reveals evidence for impaired endometrial maturation before and during early pregnancy in women who developed preeclampsia. Hypertension 65:2 (2015), 421–429.
29. Brosens, J.J., Pijnenborg, R., Brosens, I.A., The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am. J. Obstet. Gynecol. 187:5 (2002), 1416–1423.
30. Wallace, A.E., Fraser, R., Cartwright, J.E., Extravillous trophoblast and decidual natural killer cells: a remodelling partnership. Hum. Reprod. Update 18:4 (2012), 458–471.
31. Benirschke, K., Kaufmann, P., Pathology of the Human Placenta. fourth ed., 2000, Springer-Verlag, New York.
32. Craven, C.M., Morgan, T., Ward, K., Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta 19:4 (1998), 241–252.
33. Burton, G.J., Watson, A.L., Hempstock, J., Skepper, J.N., Jauniaux, E., Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J. Clin. Endocrinol. Metab. 87:6 (2002), 2954–2959.
34. Moffett, A., Colucci, F., Uterine NK cells: active regulators at the maternal-fetal interface. J. Clin. Invest. 124:5 (2014), 1872–1879.
35. Cartwright, J.E., James-Allan, L., Buckley, R.J., Wallace, A.E., The role of decidual NK cells in pregnancies with impaired vascular remodelling. J. Reprod. Immunol. 119 (2017), 81–84.
36. Xiong, S., Sharkey, A.M., Kennedy, P.R., Gardner, L., Farrell, L.E., Chazara, O., Bauer, J., Hiby, S.E., Colucci, F., Moffett, A., Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. J. Clin. Invest. 123:10 (2013), 4264–4272.
37. Ning, F., Liu, H., Lash, G.E., The role of decidual macrophages during normal and pathological pregnancy. Am. J. Reprod. Immunol. 75:3 (2016), 298–309.
38. Nancy, P., Erlebacher, A., T cell behavior at the maternal-fetal interface. Int. J. Dev. Biol. 58:2–4 (2014), 189–198.
39. Lockwood, C.J., Yen, C.F., Basar, M., Kayisli, U.A., Martel, M., Buhimschi, I., Buhimschi, C., Huang, S.J., Krikun, G., Schatz, F., Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am. J. Pathol. 172:6 (2008), 1571–1579.
40. Basar, M., Yen, C.F., Buchwalder, L.F., Murk, W., Huang, S.J., Godlewski, K., Kocamaz, E., Arda, O., Schatz, F., Lockwood, C.J., Kayisli, U.A., Preeclampsia-related increase of interleukin-11 expression in human decidual cells. Reproduction 140:4 (2010), 605–612.
41. Hara, N., Fujii, T., Okai, T., Taketani, Y., Histochemical demonstration of interleukin-2 in decidua cells of patients with preeclampsia. Am. J. Reprod. Immunol. 34:1 (1995), 44–51.
42. Wilczynski, J.R., Tchorzewski, H., Glowacka, E., Banasik, M., Lewkowicz, P., Szpakowski, M., Zeman, K., Wilczynski, J., Cytokine secretion by decidual lymphocytes in transient hypertension of pregnancy and pre-eclampsia. Mediat. Inflamm. 11:2 (2002), 105–111.
43. Huang, S.J., Zenclussen, A.C., Chen, C.P., Basar, M., Yang, H., Arcuri, F., Li, M., Kocamaz, E., Buchwalder, L., Rahman, M., Kayisli, U., Schatz, F., Toti, P., Lockwood, C.J., The implication of aberrant GM-CSF expression in decidual cells in the pathogenesis of preeclampsia. Am. J. Pathol. 177:5 (2010), 2472–2482.
44. Rahimzadeh, M., Norouzian, M., Arabpour, F., Naderi, N., Regulatory T-cells and preeclampsia: an overview of literature. Expert Rev. Clin. Immunol. 12:2 (2016), 209–227.
45. Hsu, P., Santner-Nanan, B., Dahlstrom, J.E., Fadia, M., Chandra, A., Peek, M., Nanan, R., Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am. J. Pathol. 181:6 (2012), 2149–2160.
46. Faas, M.M., Spaans, F., De Vos, P., Monocytes and macrophages in pregnancy and pre-eclampsia. Front. Immunol., 5, 2014, 298.
47. Schonkeren, D., van der Hoorn, M.L., Khedoe, P., Swings, G., van Beelen, E., Claas, F., van Kooten, C., de Heer, E., Scherjon, S., Differential distribution and phenotype of decidual macrophages in preeclamptic versus control pregnancies. Am. J. Pathol. 178:2 (2011), 709–717.
48. Prefumo, F., Sebire, N.J., Thilaganathan, B., Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices. Hum. Reprod. 19:1 (2004), 206–209.
49. Guzin, K., Tomruk, S., Tuncay, Y.A., Naki, M., Sezginsoy, S., Zemheri, E., Yucel, N., Kanadikirik, F., The relation of increased uterine artery blood flow resistance and impaired trophoblast invasion in pre-eclamptic pregnancies. Arch. Gynecol. Obstet. 272:4 (2005), 283–288.
50. Myatt, L., Clifton, R.G., Roberts, J.M., Spong, C.Y., Hauth, J.C., Varner, M.W., Wapner, R.J., Thorp, J.M. Jr., Mercer, B.M., Grobman, W.A., Ramin, S.M., Carpenter, M.W., Samuels, P., Sciscione, A., Harper, M., Tolosa, J.E., Saade, G., Sorokin, Y., Anderson, G.D., H. Eunice Kennedy Shriver National Institute of Child, N. Human Development Maternal-Fetal Medicine Units. The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population. Obstet. Gynecol. 120:4 (2012), 815–822.
51. Conde-Agudelo, A., Romero, R., Roberts, J.M., Tests to predict preeclampsia. Taylor, R.N., Roberts, J.M., Cunningham, F.G., Lindheimer, M.D., (eds.) Chesley's Hypertensive Disorders in Pregnancy, 2015, Academic Press, San Diego, CA, 221–251.
52. de Groot, C.J., O'Brien, T.J., Taylor, R.N., Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia. Am. J. Obstet. Gynecol. 175:1 (1996), 24–29.
53. Hietala, R., Pohja-Nylander, P., Rutanen, E.M., Laatikainen, T., Serum insulin-like growth factor binding protein-1 at 16 weeks and subsequent preeclampsia. Obstet. Gynecol. 95:2 (2000), 185–189.
54. Anim-Nyame, N., Hills, F.A., Sooranna, S.R., Steer, P.J., Johnson, M.R., A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia. Hum. Reprod. 15:10 (2000), 2215–2219.
55. Grobman, W.A., Kazer, R.R., Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia. Obstet. Gynecol. 97:4 (2001), 521–526.
56. Ning, Y., Williams, M.A., Vadachkoria, S., Muy-Rivera, M., Frederick, I.O., Luthy, D.A., Maternal plasma concentrations of insulinlike growth factor-1 and insulinlike growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia. Clin. Biochem. 37:11 (2004), 968–973.
57. Vatten, L.J., Nilsen, T.I., Juul, A., Jeansson, S., Jenum, P.A., Eskild, A., Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia. Eur. J. Endocrinol. 158:1 (2008), 101–105.
58. Founds, S.A., Conley, Y.P., Lyons-Weiler, J.F., Jeyabalan, A., Hogge, W.A., Conrad, K.P., Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 30:1 (2009), 15–24.
59. Rajakumar, A., Conrad, K.P., Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta. Biol. Reprod. 63:2 (2000), 559–569.
60. Rajakumar, A., Brandon, H.M., Daftary, A., Ness, R., Conrad, K.P., Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta 25:10 (2004), 763–769.
61. Rajakumar, A., Jeyabalan, A., Markovic, N., Ness, R., Gilmour, C., Conrad, K.P., Placental HIF-1 alpha, HIF-2 alpha, membrane and soluble VEGF receptor-1 proteins are not increased in normotensive pregnancies complicated by late-onset intrauterine growth restriction. Am. J. Physiol. 293:2 (2007), R766–R774.
62. Kohl, P., Crampin, E.J., Quinn, T.A., Noble, D., Systems biology: an approach. Clin. Pharmacol. Ther. 88:1 (2010), 25–33.
63. Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T.I., Manaster, I., Gazit, R., Yutkin, V., Benharroch, D., Porgador, A., Keshet, E., Yagel, S., Mandelboim, O., Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12:9 (2006), 1065–1074.
64. Robson, A., Harris, L.K., Innes, B.A., Lash, G.E., Aljunaidy, M.M., Aplin, J.D., Baker, P.N., Robson, S.C., Bulmer, J.N., Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J. 26:12 (2012), 4876–4885.
65. Smith, S.D., Dunk, C.E., Aplin, J.D., Harris, L.K., Jones, R.L., Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am. J. Pathol. 174:5 (2009), 1959–1971.
66. Eastabrook, G., Hu, Y., von Dadelszen, P., The role of decidual natural killer cells in normal placentation and in the pathogenesis of preeclampsia. J. Obstet. Gynaecol. Can. 30:6 (2008), 467–476.
67. Duncan, W.C., Shaw, J.L., Burgess, S., McDonald, S.E., Critchley, H.O., Horne, A.W., Ectopic pregnancy as a model to identify endometrial genes and signaling pathways important in decidualization and regulated by local trophoblast. PLoS One, 6(8), 2011, e23595.
68. Koopman, L.A., Kopcow, H.D., Rybalov, B., Boyson, J.E., Orange, J.S., Schatz, F., Masch, R., Lockwood, C.J., Schachter, A.D., Park, P.J., Strominger, J.L., Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198:8 (2003), 1201–1212.
69. Burney, R.O., Talbi, S., Hamilton, A.E., Vo, K.C., Nyegaard, M., Nezhat, C.R., Lessey, B.A., Giudice, L.C., Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 148:8 (2007), 3814–3826.
70. Talbi, S., Hamilton, A.E., Vo, K.C., Tulac, S., Overgaard, M.T., Dosiou, C., Le Shay, N., Nezhat, C.N., Kempson, R., Lessey, B.A., Nayak, N.R., Giudice, L.C., Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 147:3 (2006), 1097–1121.
71. Kopcow, H.D., Eriksson, M., Mselle, T.F., Damrauer, S.M., Wira, C.R., Sentman, C.L., Strominger, J.L., Human decidual NK cells from gravid uteri and NK cells from cycling endometrium are distinct NK cell subsets. Placenta 31:4 (2010), 334–338.
72. Gustafsson, C., Mjosberg, J., Matussek, A., Geffers, R., Matthiesen, L., Berg, G., Sharma, S., Buer, J., Ernerudh, J., Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One, 3(4), 2008, e2078.
73. Meng, T., Chen, H., Sun, M., Wang, H., Zhao, G., Wang, X., Identification of differential gene expression profiles in placentas from preeclamptic pregnancies versus normal pregnancies by DNA microarrays. OMICS 16:6 (2012), 301–311.
74. Vaiman, D., Calicchio, R., Miralles, F., Landscape of transcriptional deregulations in the preeclamptic placenta. PLoS One, 8(6), 2013, e65498.
75. van Uitert, M., Moerland, P.D., Enquobahrie, D.A., Laivuori, H., van der Post, J.A., Ris-Stalpers, C., Afink, G.B., Meta-analysis of placental transcriptome data identifies a novel molecular pathway related to preeclampsia. PLoS One, 10(7), 2015, e0132468.
76. Winn, V.D., Gormley, M., Fisher, S.J., The impact of preeclampsia on gene expression at the maternal-fetal interface. Pregnancy Hypertens 1:1 (2011), 100–108.
77. Yong, H.E., Melton, P.E., Johnson, M.P., Freed, K.A., Kalionis, B., Murthi, P., Brennecke, S.P., Keogh, R.J., Moses, E.K., Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes. PLoS One, 10(5), 2015, e0128230.
78. Loset, M., Mundal, S.B., Johnson, M.P., Fenstad, M.H., Freed, K.A., Lian, I.A., Eide, I.P., Bjorge, L., Blangero, J., Moses, E.K., Austgulen, R., A transcriptional profile of the decidua in preeclampsia. Am. J. Obstet. Gynecol., 204(1), 2011, 84 e1–27.
79. Schulte, M.M., Tsai, J.H., Moley, K.H., Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation. Reprod. Sci. 22:1 (2015), 6–14.
80. Bellver, J., Martinez-Conejero, J.A., Labarta, E., Alama, P., Melo, M.A., Remohi, J., Pellicer, A., Horcajadas, J.A., Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome. Fertil. Steril. 95:7 (2011), 2335–2341 2341 e1–8.
81. Rhee, J.S., Saben, J.L., Mayer, A.L., Schulte, M.B., Asghar, Z., Stephens, C., Chi, M.M., Moley, K.H., Diet-induced obesity impairs endometrial stromal cell decidualization: a potential role for impaired autophagy. Hum. Reprod. 31:6 (2016), 1315–1326.
82. Piltonen, T.T., Polycystic ovary syndrome: endometrial markers. Best. Pract. Res. Clin. Obstet. Gynaecol. 37 (2016), 66–79.
83. Jakubowicz, D.J., Essah, P.A., Seppala, M., Jakubowicz, S., Baillargeon, J.P., Koistinen, R., Nestler, J.E., Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy. J. Clin. Endocrinol. Metab. 89:2 (2004), 833–839.
84. Yu, H.F., Chen, H.S., Rao, D.P., Gong, J., Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Med. Baltim., 95(51), 2016, e4863.
85. Sween, L.K., Althouse, A.D., Roberts, J.M., Early-pregnancy percent body fat in relation to preeclampsia risk in obese women. Am J Obstet Gynecol, 212(1), 2015, 84 e1–7.
86. Roberts, J.M., Bodnar, L.M., Patrick, T.E., Powers, R.W., The role of obesity in preeclampsia. Pregnancy Hypertens. 1:1 (2011), 6–16.
87. Norambuena, J., Pijnenborg, R., Brosens, I., Decidual changes in the endometrium and morphological adaptation of the associated supplying arteries in the normal and diabetic pseudopregnant rat. Placenta 5:3 (1984), 249–260.
88. Garris, D.R., Effects of diabetes on uterine condition, decidualization, vascularization, and corpus luteum function in the pseudopregnant rat. Endocrinology 122:2 (1988), 665–672.
89. Weissgerber, T.L., Mudd, L.M., Preeclampsia and diabetes. Curr. Diab Rep., 15(3), 2015, 9.
90. Glavind, M.T., Forman, A., Arendt, L.H., Nielsen, K., Henriksen, T.B., Endometriosis and pregnancy complications: a Danish cohort study. Fertil. Steril. 107:1 (2017), 160–166.
91. Bulun, S.E., Endometriosis. N. Engl. J. Med. 360:3 (2009), 268–279.
92. Yu, J., Boicea, A., Barrett, K.L., James, C.O., Bagchi, I.C., Bagchi, M.K., Nezhat, C., Sidell, N., Taylor, R.N., Reduced connexin 43 in eutopic endometrium and cultured endometrial stromal cells from subjects with endometriosis. Mol. Hum. Reprod. 20:3 (2014), 260–270.
93. Ormazabal, P., Romero, C., Quest, A.F., Vega, M., Testosterone modulates the expression of molecules linked to insulin action and glucose uptake in endometrial cells. Horm. Metab. Res. 45:9 (2013), 640–645.
94. Cermik, D., Selam, B., Taylor, H.S., Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88:1 (2003), 238–243.
95. Nuno-Ayala, M., Guillen, N., Arnal, C., Lou-Bonafonte, J.M., de Martino, A., Garcia-de-Jalon, J.A., Gascon, S., Osaba, L., Osada, J., Navarro, M.A., Cystathionine beta-synthase deficiency causes infertility by impairing decidualization and gene expression networks in uterus implantation sites. Physiol. Genomics 44:14 (2012), 702–716.
96. Weiss, G., Goldsmith, L.T., Taylor, R.N., Bellet, D., Taylor, H.S., Inflammation in reproductive disorders. Reprod. Sci. 16:2 (2009), 216–229.
97. Sakai, N., Maruyama, T., Sakurai, R., Masuda, H., Yamamoto, Y., Shimizu, A., Kishi, I., Asada, H., Yamagoe, S., Yoshimura, Y., Involvement of histone acetylation in ovarian steroid-induced decidualization of human endometrial stromal cells. J. Biol. Chem. 278:19 (2003), 16675–16682.
98. Estella, C., Herrer, I., Atkinson, S.P., Quinonero, A., Martinez, S., Pellicer, A., Simon, C., Inhibition of histone deacetylase activity in human endometrial stromal cells promotes extracellular matrix remodelling and limits embryo invasion. PLoS One, 7(1), 2012, e30508.
99. Nancy, P., Tagliani, E., Tay, C.S., Asp, P., Levy, D.E., Erlebacher, A., Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science 336:6086 (2012), 1317–1321.
100. Tabbaa, Z.M., Zheng, Y., Daftary, G.S., KLF11 epigenetically regulates glycodelin-A, a marker of endometrial biology via histone-modifying chromatin mechanisms. Reprod. Sci. 21:3 (2014), 319–328.
101. Tamura, I., Sato, S., Okada, M., Tanabe, M., Lee, L., Maekawa, R., Asada, H., Yamagata, Y., Tamura, H., Sugino, N., Importance of C/EBPbeta binding and histone acetylation status in the promoter regions for induction of IGFBP-1, PRL, and Mn-SOD by cAMP in human endometrial stromal cells. Endocrinology 155:1 (2014), 275–286.
102. Kim, S.Y., Romero, R., Tarca, A.L., Bhatti, G., Kim, C.J., Lee, J., Elsey, A., Than, N.G., Chaiworapongsa, T., Hassan, S.S., Kang, G.H., Kim, J.S., Methylome of fetal and maternal monocytes and macrophages at the feto-maternal interface. Am. J. Reprod. Immunol. 68:1 (2012), 8–27.
103. Yamagata, Y., Asada, H., Tamura, I., Lee, L., Maekawa, R., Taniguchi, K., Taketani, T., Matsuoka, A., Tamura, H., Sugino, N., DNA methyltransferase expression in the human endometrium: down-regulation by progesterone and estrogen. Hum. Reprod. 24:5 (2009), 1126–1132.
104. Guerin, L.R., Moldenhauer, L.M., Prins, J.R., Bromfield, J.J., Hayball, J.D., Robertson, S.A., Seminal fluid regulates accumulation of FOXP3+ regulatory T cells in the preimplantation mouse uterus through expanding the FOXP3+ cell pool and CCL19-mediated recruitment. Biol. Reprod. 85:2 (2011), 397–408.
105. Robertson, S.A., Bromfield, J.J., Tremellen, K.P., Seminal 'priming' for protection from pre-eclampsia-a unifying hypothesis. J. Reprod. Immunol. 59:2 (2003), 253–265.
106. Masoudian, P., Nasr, A., de Nanassy, J., Fung-Kee-Fung, K., Bainbridge, S.A., El Demellawy, D., Oocyte donation pregnancies and the risk of preeclampsia or gestational hypertension: a systematic review and metaanalysis. Am. J. Obstet. Gynecol. 214:3 (2016), 328–339.
107. Opdahl, S., Henningsen, A.A., Tiitinen, A., Bergh, C., Pinborg, A., Romundstad, P.R., Wennerholm, U.B., Gissler, M., Skjaerven, R., Romundstad, L.B., Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum. Reprod. 30:7 (2015), 1724–1731.
108. Chen, Z.J., Shi, Y., Sun, Y., Zhang, B., Liang, X., Cao, Y., Yang, J., Liu, J., Wei, D., Weng, N., Tian, L., Hao, C., Yang, D., Zhou, F., Shi, J., Xu, Y., Li, J., Yan, J., Qin, Y., Zhao, H., Zhang, H., Legro, R.S., Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N. Engl. J. Med. 375:6 (2016), 523–533.
109. Ishihara, O., Araki, R., Kuwahara, A., Itakura, A., Saito, H., Adamson, G.D., Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan. Fertil. Steril. 101:1 (2014), 128–133.
110. Lopez-Garcia, P., Moreira, D., Open questions on the origin of eukaryotes. Trends Ecol. Evol. 30:11 (2015), 697–708.
111. Costello, E.K., Lauber, C.L., Hamady, M., Fierer, N., Gordon, J.I., Knight, R., Bacterial community variation in human body habitats across space and time. Science 326:5960 (2009), 1694–1697.
112. Cho, I., Blaser, M.J., The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13:4 (2012), 260–270.
113. Mitchell, C.M., Haick, A., Nkwopara, E., Garcia, R., Rendi, M., Agnew, K., Fredricks, D.N., Eschenbach, D., Colonization of the upper genital tract by vaginal bacterial species in nonpregnant women. Am. J. Obstet. Gynecol., 212(5), 2015, 611 e1–9.
114. Verstraelen, H., Vilchez-Vargas, R., Desimpel, F., Jauregui, R., Vankeirsbilck, N., Weyers, S., Verhelst, R., De Sutter, P., Pieper, D.H., Van De Wiele, T., Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene. PeerJ, 4, 2016, e1602.
115. Moreno, I., Codoner, F.M., Vilella, F., Valbuena, D., Martinez-Blanch, J.F., Jimenez-Almazan, J., Alonso, R., Alama, P., Remohi, J., Pellicer, A., Ramon, D., Simon, C., Evidence that the endometrial microbiota has an effect on implantation success or failure. Am. J. Obstet. Gynecol. 215:6 (2016), 684–703.
116. Woo, V., Alenghat, T., Host-microbiota interactions: epigenomic regulation. Curr. Opin. Immunol. 44 (2017), 52–60.
117. van Oostwaard, M.F., Langenveld, J., Schuit, E., Papatsonis, D.N., Brown, M.A., Byaruhanga, R.N., Bhattacharya, S., Campbell, D.M., Chappell, L.C., Chiaffarino, F., Crippa, I., Facchinetti, F., Ferrazzani, S., Ferrazzi, E., Figueiro-Filho, E.A., Gaugler-Senden, I.P., Haavaldsen, C., Lykke, J.A., Mbah, A.K., Oliveira, V.M., Poston, L., Redman, C.W., Salim, R., Thilaganathan, B., Vergani, P., Zhang, J., Steegers, E.A., Mol, B.W., Ganzevoort, W., Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis. Am. J. Obstet. Gynecol., 212(5), 2015, 624 e1–17.
118. Conrad, K.P., G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention. Hum. Reprod. Update 22:5 (2016), 647–664.
119. Rabaglino, M.B., Post Uiterweer, E.D., Conrad, K.P., Evidence for partial overlap of molecular etiology between preeclampsia and decidualization disorders. Reprod. Sci., 24, 2017, 91A.